The COVID-19 Long Haul Foundation

Treatment, Referral & Educational Support for COVID-19 Illnesses & Vaccine Injury

Cardiovascular Sequelae of the COVID-19 Vaccines

James N. Nitz • Kylie K. Ruprecht • Lukas J. Henjum •et. al., DOI: 10.7759/cureus.82041  Abstract Vaccines against COVID-19 present a key tool in lowering the morbidity, mortality, and transmission of the disease, but they also […]

A Unique Case of Unprovoked Pulmonary Venous Thrombosis in a Postpartum Female Following COVID-19 Infection

Jordan Lipschutz • Sophia H. Ji • Mohammad Q. Jafri • Ambica Nair • Brian Kerr, 2024, DOI: 10.7759/cureus.64893 Abstract SARS-CoV-2 can induce a hypercoagulable state, occasionally resulting in pulmonary venous thrombosis (PVT) due to inflammation and endothelial injury. […]

SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation

Authors: Luca Perico 1, Marina Morigi 1, et. al.; 2022 Mar 7;13:827146. doi: 10.3389/fimmu. 2022.827146. eCollection 2022. Abstract Microvascular thrombosis is associated with multiorgan failure and mortality in coronavirus disease 2019 (COVID-19). Although thrombotic complications may […]

Doxycycline’s Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study

Khalid Al Sulaiman, MBA, BCCCP, BCNSP, FCCM https://orcid.org/0000-0002-5547-2043,  Ohoud Aljuhani, PharmD, […], and Ghassan Alghamdi, MD Abstract Doxycycline has revealed potential effects in animal studies to prevent thrombosis and reduce mortality. However, less is known about its antithrombotic role […]

Diagnosis of venous thromboembolic diseases in people with covid-19: summary of updated NICE guidance

BMJ 2023; 383 doi: https://doi.org/10.1136/bmj.p2204 (Published 12 October 2023)Cite this as: BMJ 2023;383:p2204, Sarah Boyce, senior technical analyst1,  Emma McFarlane, Susan Harrison, Terry McCormack What you need to know In venous thromboembolism, a blood clot usually forms […]